Jan 29, 2016 14:00 pm UTC| Business
ATLANTA, Jan. 29, 2016 -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the “Company”), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have...
Diana Shipping Inc. Announces Time Charter Contract for m/v Houston With SwissMarine
Jan 29, 2016 13:55 pm UTC| Business
ATHENS, Greece, Jan. 29, 2016 -- Diana Shipping Inc. (NYSE:DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned...
MedAssets Named Category Leader in “2015/2016 Best in KLAS” Report
Jan 29, 2016 13:30 pm UTC| Business
ATLANTA, Jan. 29, 2016 -- MedAssets ranked #1 in claims management and revenue cycle outsourcing in the newly published “2015/2016 Best in KLAS” report, which is based on industry feedback. The report recognizes...
Tuesday Morning Corporation Announces Second Quarter Fiscal 2016 Results
Jan 29, 2016 13:30 pm UTC| Business
DALLAS, Jan. 29, 2016 -- Tuesday Morning Corporation (NASDAQ:TUES), a leading off-price retailer with over 750 stores across the United States specializing in selling deeply discounted, upscale decorative home...
Benefitfocus to Present at the 2016 Goldman Sachs Technology & Internet Conference
Jan 29, 2016 13:30 pm UTC| Business
CHARLESTON, S.C., Jan. 29, 2016 -- Benefitfocus, Inc. (NASDAQ:BNFT), a provider of a leading cloud-based benefits management platform, today announced that its Chief Executive Officer, Shawn Jenkins, and its Chief...
Jan 29, 2016 13:00 pm UTC| Business
CHARLOTTE, N.C., Jan. 29, 2016 -- CommunityOne Bancorp (“Company”) (NASDAQ:COB), the holding company for CommunityOne Bank, N.A. (“Bank”), today announced its unaudited financial results for the quarter ended December...
Genocea Commences Dosing in Phase 2b Study for Genital Herpes Treatment, GEN-003
Jan 29, 2016 13:00 pm UTC| Business
- Top-line viral shedding data expected in mid-2016 -- Six month clinical efficacy data against potential Phase 3 endpoints expected in 2H 2016 - CAMBRIDGE, Mass., Jan. 29, 2016 -- Genocea Biosciences, Inc....